- Home
- PHX vs KOD Comparison
PHX vs KOD Comparison
Compare PHX & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHX
- KOD
- Stock Information
- Founded
- PHX 1926
- KOD 2009
- Country
- PHX United States
- KOD United States
- Employees
- PHX 20
- KOD N/A
- Industry
- PHX Oil & Gas Production
- KOD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PHX Energy
- KOD Health Care
- Exchange
- PHX Nasdaq
- KOD Nasdaq
- Market Cap
- PHX 132.0M
- KOD 121.5M
- IPO Year
- PHX N/A
- KOD 2018
- Fundamental
- Price
- PHX $3.52
- KOD $2.84
- Analyst Decision
- PHX Strong Buy
- KOD Hold
- Analyst Count
- PHX 2
- KOD 5
- Target Price
- PHX $4.90
- KOD $3.25
- AVG Volume (30 Days)
- PHX 50.8K
- KOD 164.1K
- Earning Date
- PHX 11-06-2024
- KOD 11-12-2024
- Dividend Yield
- PHX 4.61%
- KOD N/A
- EPS Growth
- PHX N/A
- KOD N/A
- EPS
- PHX 0.15
- KOD N/A
- Revenue
- PHX $33,407,691.00
- KOD N/A
- Revenue This Year
- PHX $5.74
- KOD N/A
- Revenue Next Year
- PHX $22.86
- KOD N/A
- P/E Ratio
- PHX $22.72
- KOD N/A
- Revenue Growth
- PHX N/A
- KOD N/A
- 52 Week Low
- PHX $2.95
- KOD $1.37
- 52 Week High
- PHX $3.81
- KOD $7.77
- Technical
- Relative Strength Index (RSI)
- PHX 70.99
- KOD 62.04
- Support Level
- PHX $3.37
- KOD $2.54
- Resistance Level
- PHX $3.45
- KOD $2.75
- Average True Range (ATR)
- PHX 0.05
- KOD 0.15
- MACD
- PHX 0.01
- KOD 0.02
- Stochastic Oscillator
- PHX 100.00
- KOD 100.00
About PHX PHX Minerals Inc.
PHX Minerals Inc is an oil and natural gas mineral company that has employed a plan to shift the core of its business away from drilling and toward perpetual mineral and natural gas ownership. The company owns substantial mineral acreage, principally in Oklahoma, North Dakota, Texas, New Mexico, and Arkansas, but still maintains legacy interests in natural gas and oil properties that have retired operations. The revenues is derived from royalties granted from the production and sale of natural gas, oil and NGL, and the remaining portion of its revenues is derived from the production and sale of natural gas, oil and NGL on its working interests.
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is KSI-301, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD.